Percutaneous image-guided biopsy of prostate cancer metastases yields samples suitable for genomics and personalised oncology

Clinical and Experimental Metastasis

Volumn 31, Issue 2, 2014, Pages 159-167

  Hong, Matthew K H ^a,b   Sapre, Nikhil ^a,b   Phal, Pramit M ^c   MacIntyre, Geoff ^a   Chin, Xiaowen ^a,b   Pedersen, John S ^d,e   Ryan, Andrew ^d   Kerger, Michael ^a,b   Costello, Anthony J ^a,b   Corcoran, Niall M ^a,b   Hovens, Christopher M ^a,b  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b Australian Prostate Cancer Research Centre at Epworth   (Australia)

^c ROYAL MELBOURNE HOSPITAL   (Australia)

^d Tissupath Pty Ltd   (Australia)

^e MONASH UNIVERSITY   (Australia)

Author keywords

Biorepository; Genomics; Guided biopsy; Metastasis; Prostate cancer

Indexed keywords

DNA; GENOMIC DNA; RNA;

ARTICLE; BIOPSY NEEDLE; BONE METASTASIS; CANCER SURGERY; CHROMOSOME ABERRATION; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; DNA EXTRACTION; DNA HYBRIDIZATION; FROZEN SECTION; GENE DOSAGE; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENOMICS; HUMAN; HUMAN TISSUE; IMAGE GUIDED BIOPSY; MALE; ONCOLOGY; PERCUTANEOUS BIOPSY; PROSTATE CANCER; RNA EXTRACTION; SINGLE NUCLEOTIDE POLYMORPHISM; TUMOR BIOPSY; ULTRASOUND;

BIOPSY; DNA COPY NUMBER VARIATIONS; GENOME, HUMAN; HUMANS; INDIVIDUALIZED MEDICINE; MALE; NEOPLASM METASTASIS; PLOIDIES; POLYMORPHISM, SINGLE NUCLEOTIDE; PROSTATIC NEOPLASMS;

EID: 84893243626     PISSN: 02620898     EISSN: 15737276     Source Type: Journal    
DOI: 10.1007/s10585-013-9617-2     Document Type: Article

References (36)

1. Meyerson M, Gabriel S, Getz G (2010) Advances in understanding cancer genomes through second-generation sequencing. Nat Rev Genet 11(10):685-696
2. Macconaill LE, Garraway LA (2010) Clinical implications of the cancer genome. J Clin Oncol 28(35):5219-5228
3. Kim ES, Herbst RS, Wistuba II et al (2011) The battle trial: personalizing therapy for lung cancer. Cancer Discov 1(1):44-53
4. Lynch TJ, Bell DW, Sordella R et al (2004) Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib. N Engl J Med 350(21):2129-2139
5. Tran B, Dancey JE, Kamel-Reid S et al (2012) Cancer genomics: technology, discovery, and translation. J Clin Oncol 30(6):647-660
6. Vakiani E, Janakiraman M, Shen R et al (2012) Comparative genomic analysis of primary versus metastatic colorectal carcinomas. J Clin Oncol 30(24):2956-2962
7. Tie J, Gibbs P, Lipton L et al (2011) Optimizing targeted therapeutic development: analysis of a colorectal cancer patient population with the BRAF (V600E) mutation. Int J Cancer 128(9):2075-2084
8. Diaz Z (2012) Quebec clinical research organization in cancer consortium. Feasibility and challenges of a biopsy-driven and biomarker discovery clinical trial in metastatic colorectal cancer to identify signatures of clinical resistance. ASCO Meeting Abstracts; 30 (15-suppl), e14108
9. Roychowdhury S, Iyer MK, Robinson DR, et al. (2011) Personalized oncology through integrative high-throughput sequencing: a pilot study. Sci Transl Med 3(111) 111ra21
10. Thomas RK, Baker AC, Debiasi RM et al (2007) High-throughput oncogene mutation profiling in human cancer. Nat Genet 39(3):347-351
11. MacConaill LE, Campbell CD, Kehoe SM et al (2009) Profiling critical cancer gene mutations in clinical tumor samples. PLoS ONE 4(11):e7887
12. Dias-Santagata D, Akhavanfard S, David SS et al (2010) Rapid targeted mutational analysis of human tumours: a clinical platform to guide personalized cancer medicine. EMBO Mol Med 2(5):146-158
13. Corless CL (2011) Medicine Personalized cancer diagnostics. Science 334(6060):1217-1218
14. Garraway LA (2012) Concordance and discordance in tumor genomic profiling. J Clin Oncol 30(24):2937-2939
15. Cawthorn TR, Amir E, Broom R et al (2009) Mechanisms and pathways of bone metastasis: challenges and pitfalls of performing molecular research on patient samples. Clin Exp Metastasis 26(8):935-943
16. Hilton JF, Amir E, Hopkins S et al (2011) Acquisition of metastatic tissue from patients with bone metastases from breast cancer. Breast Cancer Res Treat 129(3):761-765
17. Amir E, Clemons M, Purdie CA et al (2012) Tissue confirmation of disease recurrence in breast cancer patients: pooled analysis of multi-centre, multi-disciplinary prospective studies. Cancer Treat Rev 38(6):708-714
18. Amir E, Miller N, Geddie W et al (2012) Prospective study evaluating the impact of tissue confirmation of metastatic disease in patients with breast cancer. J Clin Oncol 30(6):587-592
19. Hudson TJ, Anderson W, Artez A et al (2010) International network of cancer genome projects. Nature 464(7291):993-998
20. Blow N (2009) Biobanking: freezer burn. Nat Methods 6(2):173-178
21. Hewitt RE (2011) Biobanking: the foundation of personalized medicine. Curr Opin Oncol 23(1):112-119
22. Alers JC, Krijtenburg PJ, Vissers KJ et al (1999) Effect of bone decalcification procedures on DNA in situ hybridization and comparative genomic hybridization. EDTA is highly preferable to a routinely used acid decalcifier. J Histochem Cytochem 47(5):703-710
23. Xu C, Houck JR, Fan W et al (2008) Simultaneous isolation of DNA and RNA from the same cell population obtained by laser capture microdissection for genome and transcriptome profiling. J Mol Diagn 10(2):129-134
24. Van Loo P, Nordgard SH, Lingjaerde OC et al (2010) Allele-specific copy number analysis of tumors. Proc Natl Acad Sci USA 107(39):16910-16915
25. Nik-Zainal S, Van Loo P, Wedge DC et al (2012) The life history of 21 breast cancers. Cell 149(5):994-1007
26. Taylor BS, Schultz N, Hieronymus H et al (2010) Integrative genomic profiling of human prostate cancer. Cancer Cell 18(1):11-22
27. Liu W, Laitinen S, Khan S et al (2009) Copy number analysis indicates monoclonal origin of lethal metastatic prostate cancer. Nat Med 15(5):559-565
28. Wu JS, Goldsmith JD, Horwich PJ et al (2008) Bone and soft-tissue lesions: what factors affect diagnostic yield of image-guided core-needle biopsy? Radiology 248(3):962-970
29. Rimondi E, Rossi G, Bartalena T et al (2011) Percutaneous CT-guided biopsy of the musculoskeletal system: results of 2027 cases. Eur J Radiol 77(1):34-42
30. Amir E, Ooi WS, Simmons C et al (2008) Discordance between receptor status in primary and metastatic breast cancer: an exploratory study of bone and bone marrow biopsies. Clin Oncol (R Coll Radiol) 20(10):763-768
31. Yau C, Holmes CC (2008) CNV discovery using SNP genotyping arrays. Cytogenet Genome Res 123(1-4):307-312
32. Li A, Liu Z, Lezon-Geyda K et al (2011) GPHMM: an integrated hidden Markov model for identification of copy number alteration and loss of heterozygosity in complex tumor samples using whole genome SNP arrays. Nucleic Acids Res 39(12):4928-4941
33. Wineinger NE, Kennedy RE, Erickson SW et al (2008) Statistical issues in the analysis of DNA copy number variations. Int J Comput Biol Drug Des 1(4):368-395
34. Stoecklein NH, Klein CA (2010) Genetic disparity between primary tumours, disseminated tumour cells, and manifest metastasis. Int J Cancer 126(3):589-598
35. Dhir R (2008) Prostate cancer biobanking. Curr Opin Urol 18(3):309-314
36. Simmons C, Miller N, Geddie W et al (2009) Does confirmatory tumor biopsy alter the management of breast cancer patients with distant metastases? Ann Oncol 20(9):1499-1504